128 related articles for article (PubMed ID: 11987156)
1. Worry and attitude of men in at-risk families for prostate cancer about genetic susceptibility and genetic testing.
Cormier L; Valéri A; Azzouzi R; Fournier G; Cussenot O; Berthon P; Guillemin F; Mangin P
Prostate; 2002 Jun; 51(4):276-85. PubMed ID: 11987156
[TBL] [Abstract][Full Text] [Related]
2. Adherence to an annual PSA screening program over 3 years for brothers and sons of men with prostate cancer.
Roumier X; Azzouzi R; Valéri A; Guillemin F; Fournier G; Cussenot O; Mangin P; Cormier L
Eur Urol; 2004 Mar; 45(3):280-5; author reply 285-6. PubMed ID: 15036671
[TBL] [Abstract][Full Text] [Related]
3. Attitudes toward colon cancer gene testing: survey of relatives of colon cancer patients.
Petersen GM; Larkin E; Codori AM; Wang CY; Booker SV; Bacon J; Giardiello FM; Boyd PA
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):337-44. PubMed ID: 10207638
[TBL] [Abstract][Full Text] [Related]
4. Interest in genetic testing for colon cancer susceptibility: cognitive and emotional correlates.
Croyle RT; Lerman C
Prev Med; 1993 Mar; 22(2):284-92. PubMed ID: 8483865
[TBL] [Abstract][Full Text] [Related]
5. Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
Macefield RC; Lane JA; Metcalfe C; Down L; Neal DE; Hamdy FC; Donovan JL
Eur J Cancer; 2009 Sep; 45(14):2569-73. PubMed ID: 19375907
[TBL] [Abstract][Full Text] [Related]
6. Sons of men with prostate cancer: their attitudes regarding possible inheritance of prostate cancer, screening, and genetic testing.
Bratt O; Kristoffersson U; Lundgren R; Olsson H
Urology; 1997 Sep; 50(3):360-5. PubMed ID: 9301698
[TBL] [Abstract][Full Text] [Related]
7. Health motivation and emotional vigilance in genetic testing for prostate cancer risk.
Li Y; Doukas DJ
Clin Genet; 2004 Dec; 66(6):512-6. PubMed ID: 15521978
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer screening in men with a family history of prostate cancer: the role of partners in influencing men's screening uptake.
Meiser B; Cowan R; Costello A; Giles GG; Lindeman GJ; Gaff CL
Urology; 2007 Oct; 70(4):738-42. PubMed ID: 17991547
[TBL] [Abstract][Full Text] [Related]
9. [Genetic, epidemiologic and clinical study of familial prostate cancer].
Valéri A
Bull Acad Natl Med; 2002; 186(4):779-88; discussion 788-91. PubMed ID: 12412374
[TBL] [Abstract][Full Text] [Related]
10. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
[TBL] [Abstract][Full Text] [Related]
11. Screening behavior in brothers and sons of men with prostate cancer.
Cormier L; Reid K; Kwan L; Litwin MS
J Urol; 2003 May; 169(5):1715-9. PubMed ID: 12686816
[TBL] [Abstract][Full Text] [Related]
12. Relation of family history of prostate cancer to perceived vulnerability and screening behavior.
Jacobsen PB; Lamonde LA; Honour M; Kash K; Hudson PB; Pow-Sang J
Psychooncology; 2004 Feb; 13(2):80-5. PubMed ID: 14872526
[TBL] [Abstract][Full Text] [Related]
13. Psychological aspects of screening in families with hereditary prostate cancer.
Bratt O; Emanuelsson M; Grönberg H
Scand J Urol Nephrol; 2003; 37(1):5-9. PubMed ID: 12745735
[TBL] [Abstract][Full Text] [Related]
14. Attitudes and beliefs concerning prostate cancer genetic screening.
Doukas DJ; Localio AR; Li Y
Clin Genet; 2004 Nov; 66(5):445-51. PubMed ID: 15479190
[TBL] [Abstract][Full Text] [Related]
15. Family history of cancer and utilization of prostate, colorectal and skin cancer screening tests in U.S. men.
Shah M; Zhu K; Palmer RC; Wu H
Prev Med; 2007 May; 44(5):459-64. PubMed ID: 17320159
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer worry and mammography use by women with and without a family history in a population-based sample.
Andersen MR; Smith R; Meischke H; Bowen D; Urban N
Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):314-20. PubMed ID: 12692105
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer risk with positive family history, normal prostate examination findings, and PSA less than 4.0 ng/mL.
Canby-Hagino E; Hernandez J; Brand TC; Troyer DA; Higgins B; Ankerst DP; Thompson IM; Leach RJ; Parekh DJ
Urology; 2007 Oct; 70(4):748-52. PubMed ID: 17991549
[TBL] [Abstract][Full Text] [Related]
18. Cancer worry is associated with abnormal prostate-specific antigen levels in men participating in a community screening program.
Cohen L; Fouladi RT; Babaian RJ; Bhadkamkar VA; Parker PA; Taylor CC; Smith MA; Gritz ER; Basen-Engquist K
Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):610-7. PubMed ID: 12869399
[TBL] [Abstract][Full Text] [Related]
19. Anticipated reactions to genetic testing for hereditary non-polyposis colorectal cancer susceptibility.
Brodersen NH; Sutton S; Goff S; Hodgson SV; Thomas HJ
Clin Genet; 2004 Nov; 66(5):437-44. PubMed ID: 15479189
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide screen for prostate cancer susceptibility genes in men with clinically significant disease.
Chang BL; Isaacs SD; Wiley KE; Gillanders EM; Zheng SL; Meyers DA; Walsh PC; Trent JM; Xu J; Isaacs WB
Prostate; 2005 Sep; 64(4):356-61. PubMed ID: 15754351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
